144 related articles for article (PubMed ID: 34993415)
1. Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults.
Abel MK; Mann AK; Sonawane K; Kapp DS; Deshmukh AA; Chan JK
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34993415
[TBL] [Abstract][Full Text] [Related]
2. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
[TBL] [Abstract][Full Text] [Related]
3. Barrier use during oro-genital sex and oral Human Papillomavirus prevalence: Analysis of NHANES 2009-2014.
Gupta A; Perkins RB; Ortega G; Feldman S; Villa A
Oral Dis; 2019 Mar; 25(2):609-616. PubMed ID: 30367525
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
5. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
[TBL] [Abstract][Full Text] [Related]
7. Effect of vaccination against oral HPV-16 infection in high school students in the city of Cali, Colombia.
Castillo A; Osorio JC; Fernández A; Méndez F; Alarcón L; Arturo G; Herrero R; Bravo LE
Papillomavirus Res; 2019 Jun; 7():112-117. PubMed ID: 30851448
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
Six L; Leodolter S; Sings HL; Barr E; Haupt R; Joura EA
Wien Klin Wochenschr; 2008; 120(21-22):666-71. PubMed ID: 19116707
[TBL] [Abstract][Full Text] [Related]
10. Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014.
Sonawane K; Suk R; Chiao EY; Chhatwal J; Qiu P; Wilkin T; Nyitray AG; Sikora AG; Deshmukh AA
Ann Intern Med; 2017 Nov; 167(10):714-724. PubMed ID: 29049523
[TBL] [Abstract][Full Text] [Related]
11. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Secord EA; Kapogiannis BG; Thornton S; Gillison ML
Sex Transm Dis; 2015 May; 42(5):246-52. PubMed ID: 25868136
[TBL] [Abstract][Full Text] [Related]
12. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.
Taylor S; Bunge E; Bakker M; Castellsagué X
BMC Infect Dis; 2016 Jun; 16():293. PubMed ID: 27301867
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of oral HPV infection in the United States, 2009-2010.
Gillison ML; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Graubard BI; Chaturvedi AK
JAMA; 2012 Feb; 307(7):693-703. PubMed ID: 22282321
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women.
Sonawane K; Nyitray AG; Nemutlu GS; Swartz MD; Chhatwal J; Deshmukh AA
JAMA Netw Open; 2019 Dec; 2(12):e1918571. PubMed ID: 31880792
[TBL] [Abstract][Full Text] [Related]
16. Rates and determinants of oral human papillomavirus infection in young men.
Edelstein ZR; Schwartz SM; Hawes S; Hughes JP; Feng Q; Stern ME; O'Reilly S; Lee SK; Fu Xi L; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):860-7. PubMed ID: 23064535
[TBL] [Abstract][Full Text] [Related]
17. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.
Saccucci M; Franco EL; Ding L; Bernstein DI; Brown D; Kahn JA
Sex Transm Dis; 2018 Apr; 45(4):260-265. PubMed ID: 29465705
[TBL] [Abstract][Full Text] [Related]
18. Importance of Lifetime Sexual History on the Prevalence of Genital Human Papillomavirus (HPV) Among Unvaccinated Adults in the National Health and Nutrition Examination Surveys: Implications for Adult HPV Vaccination.
Rositch AF; Patel EU; Petersen MR; Quinn TC; Gravitt PE; Tobian AAR
Clin Infect Dis; 2021 May; 72(9):e272-e279. PubMed ID: 32710745
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
20. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
